Relapsing Multiple Sclerosis (RMS) Withdrawn Phase 4 Trials for Peginterferon beta-1a (DB09122)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02234869Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon TherapyTreatment